May 18, 2008

Trasylol Maker, Bayer, Recalls Blood Clotting Med From US Market

Bayer, the maker of blood clotting drug, Trasylol, announced that it plans to recall what is left of the allegedly defective medication from the US Markets - this, according to the FDA. In November of 2007, Trasylol was suspended for use in heart surgery by the FDA after a Canadian clinical study showed a heightened risk of death versus too other drugs that are used to manage blood loss during surgery.

Trasylol was previously used by patients who were at a higher risk of blood loss during coronary artery bypass surgery.

If you or a loved one has been injured or killed by Trasylol or any other defective drug, I would invite you to visit my website www.samlevine.com or contact my office, Sam Levine, Attorney at Law.


May 11, 2008

Heart Drug, Digitek, Recalled by Icelandic Drug Maker, Actavis

A drug known as Digitek administered to patients with heart problems, has been recalled by drug manufacturer, Actavis. The crux of the drug recall is that the medication itself is said to be double the thickness and strength of the normal dosage. It is believed that the consumption of this medication may lead to complications, including arrhythmia, decreased blood pressure and death.

The generic version, Digoxin, can cause a heightened risk of toxicity in patients who have or continue to experience renal failure. The proper amount of the Digoxin, notwithstanding the defective nature of the drug, is supposed to help strengthen a weak heart and suppress fluttering and erratic heartbeats. Some patients are alleging personal injuries related to the drug, including liver failure.

FDA warnings about the defective drug go back to 1999, so Actavis has got some explaining to do, especially as Digitek patients continue to claim personal injuries from the defective drug.

If you or a loved one has been injured or killed by this or any other defective drug, I would invite you to visit my website, www.samlevine.com or contact my office, Sam Levine, Attorney at Law.

April 30, 2008

Celebrex And Bextra Maker, Pfizer, Looking to Settle Injury Lawsuits

Drug maker giant, Pfizer, the maker of Celebrex and Bextra, have already reached settlements with hundreds of claimants and plaintiffs who maintain that the defective drugs caused them to have heart attacks and strokes.

Pfizer has been actively trying to settle the defective drug lawsuits involving Celebrex and Bextra and has set aside a half a billion dollars to do so. Vioxx maker Merck on the other hand is resigned to litigate the suits to trial.

If you or a loved one has been injured or killed by Celebrex, Bextra, Vioxx any other defective drug, I would invite you to please visit my website, www.samlevine.com or contact my office, Sam Levine, Attorney at Law

April 22, 2008

Trasylol Maker, Bayer, Faces Numerous Injury & Wrongful Death Claims

Following multiple studies and the recall of Trasylol, Bayer, the drug maker, is now facing a multitude of injury and wrongful death claims. The blood thinning medication was expected to be a huge money maker for Bayer, but as complications during and after surgery occurred, including amputation of limbs, kidney failure and death, Bayer under internal and FDA pressure, yanked the medicine.

The unfortunate thing is that there were other blood thinning medications besides Trasylol that could have been used during open heart surgeries that were much cheaper and safer. It is estimated that over 1,000 people per month have died as a direct result of complications brought on by Trasylol.

If you or a loved one has been injured or died as a result of Trasylol, I would encourage you to visit my website, www.samlevine.com or contact my office, Sam Levine, Attorney at Law.



April 6, 2008

Lawsuit Filed in Federal Court Against Heparin Maker Baxter Healthcare

A defective drug lawsuit has been filed in Federal Court in Illinois against Heparin maker Baxter Healthcare in the wake of a near fatal adverse reaction experienced by the user. The defective drug lawsuit seeks compensatory damages for pain and suffering as well as punitive damages as the Plaintiff asserts that Baxter knew that the Heparin was contaminated.

In March of this year, the FDA announced that the active ingredient in Heparin was contaminated at some of its manufacturing plants in China. A month prior, in February, Baxter came out and said that they voluntarily recalled its defective drug Heparin sodium injection.

If you or a loved one has been injured or died as a result of this or any other defective drug, I would invite you to visit my website, www.samlevine.com or contact my office, Sam Levine, Attorney at Law.

March 11, 2008

Link between Childhood Vaccines and Autism To Be Tested At Trial

In what is believed to be a unprecedented class action suit against the maker of childhood vaccines, some 5,000 families will be in court over the next few weeks contending that mercury contained in defective vaccine, caused autism in their children.

The families, many of whom have been waiting for close to five years for their day in court, will be making their way shortly to the "federal vaccine court", which is a special court that hears and rules on the defective vaccine suits. If the court, based upon the evidence and testimony, renders a decision in favor the the claimants, all awards will be paid out of a designated federal fund.

One family that is at the forefront of the Vaccine-Autism Claim is a family in Atlanta, Georgia, the Polings, who settled out of court, will receive money from the federal fund for people harmed by vaccine. In the lawsuit, the Polings claimed that their daughter, who was a year and a half, was administered five vaccines back in July of 2000.

The burden of proof in the federal vaccine court is identical to civil court - by a preponderance of the evidence. That is, the parents will need to prove that it is more likely than not that the vaccines caused the autism and autism-like symptoms, which should not be too difficult, given the direct and circumstantial evidence at the disposal of the Plaintiffs.

If you have any children that have been harmed or adversely effected, I would invite you to please visit my website www.samlevine.com or contact my office, Sam Levine, Attorney at Law.



March 5, 2008

Maker Of Botox, Allergan, Subpoenaed By FDA

The FDA has just issued a subpoena to Botox maker, Allergan Inc., to obtain marketing related documents from the company about the use of the defective drug for headaches. Botox is generally used to relax wrinkles. Here, however, FDA suspects that the Botox maker is attempting to promote the defective product to relieve pain from headaches, which, no pun intended, FDA is frowning upon.

FDA is presently looking at Botox and similar defective drugs in the wake of reported adverse reactions experienced by numerous people using the drug for headaches resulting in hospitalization, muscle spasm and even death.

If you or a loved one has been harmed by this or a similar defective drug, I would invite you to please visit my website, www.samlevine.com or contact my office, Sam Levine, Attorney at Law.

February 25, 2008

Thousands Die Over Delay By Bayer To Recall Bayer AG Drug

Some 22,000 people's lives were needlessly snuffed out because of Bayer's colossal failure to recall its Bayer Ag drug, Trasylol, that is used during surgery to stop and control bleeding during open heart surgery. In the fall of last year, the drug was withdrawn after the FDA requested Bayer to do so after finding out from a study that connected the medicine to organ failure requiring dialysis.

Numerous Plaintiffs have filed wrongful death lawsuits against Bayer for injuries sustained while on the defective drug and more are expected.

If you or a loved one has been affected by this or any other defective drug, I would invite you to visit my website, www.samlevine.com or contact my office, Sam Levine, Attorney at Law.


February 12, 2008

FDA Warns That Baxter's Heparin Should Not Be Used

The FDA just warned consumers and the health care community that Heparin, made by Baxter Health Care, should not be used. Heparin has been linked to numerous illnesses and the deaths of at least a handful of people.

Before FDA issued this warning, Baxter asserted that it would stop making the defective medicine after it was reported that people were experiencing allergic reactions, which occurred within minutes after ingestion and included rapid heartbeat, nausea and swelling.

If you or a loved one has been adversely affected by this or any other defective or recalled medicine, I would invite you to visit my website, www.samlevine.com or contact my office, Sam Levine, Attorney at Law.


January 25, 2008

Blood Clotting Drug, Heparin, Recalled By Baxter Health Care

Pharmaceutical giant, Baxter Healthcare has issued a drug recall on it's blood thinning drug, Heparin. The drug recall occurred on Friday, January 25, 2008 over safety concerns.

A preliminary drug recall took place on January 17 in the wake of numerous compaint from people over adverse effects, that have been reported to include abdominal pain, spiking blood pressure, nausea, shortness of breath, throat swelling and chest pain.

Baxter acknowledges that some of the adverse effects of the Heparin drug could be fatal, particularly in light of the fact that Heparin is mainly used by patients having or about to have various heart procedures. This in turn could lead to a flurry of wrongful death lawsuits.

You may be interested in reading my other article, Dennis Quaid Sues Drug Maker, Baxter Health Care, Over Defectively Designed Heparin Drug Labels.

If you have been harmed by this or any other drug, please feel free to visit my website, www.samlevine.com for more information or contact my office, Sam Levine, Attorney at Law.